comparemela.com

Latest Breaking News On - ஒழுங்குமுறை லிமிடெட் - Page 1 : comparemela.com

Investegate |Guaranty Trust Hldng Announcements | Guaranty Trust Hldng: Directorate Change

Investegate |Guaranty Trust Hldng Announcements | Guaranty Trust Hldng: Directorate Change
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

Zaria
Kaduna
Nigeria
Bayero
Nigeria-general
New-york
United-states
Lagos
Ahmadu
Borno
Hong-kong
Paris

Santhera Announces First Trading Day of New Convertible Bonds on SIX Swiss Exchange

is starting today on the SIX Swiss Exchange. On May 4, 2021, Santhera Pharmaceuticals Holding AG issued Senior Unsecured Convertible Bonds due 2024 (the 2021/24 Bonds) in the aggregate principal amount of CHF 30,270,375. The 2021/24 Bonds have been admitted to trading on the SIX Swiss Exchange. The first trading day is today, May 7, 2021. The ticker symbol of the 2021/24 Bonds is SAN21 and ISIN CH0563348744. As set out in the terms and conditions [1], the conversion period during which a bondholder may exercise the conversion rights for the 2021/24 Bonds has started on May 4, 2021, and ends seven trading days before the maturity date on August 17, 2024 (or, in case of early redemption, ten trading days prior to the date fixed for early redemption).

Pratteln
Switzerland-general
Switzerland
United-states
United-kingdom
American
Swiss
Eva-kalias
Santhera-pharmaceuticals
Head-external-communications
Swiss-exchange
Bonds

Santhera Announces Settlement of Exchange Offer and Issuance of New Senior Unsecured Convertible Bonds due 2024

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO Pratteln, Switzerland, May 4, 2021 – Santhera .

Pratteln
Switzerland-general
Switzerland
United-states
United-kingdom
American
Swiss
Eva-kalias
Basler-kantonalbank
Santhera-pharmaceuticals
Swiss-financial-services-act-fin
Head-external-communications

Santhera Pharmaceuticals Holding AG: Santhera Announces Settlement of Exchange Offer and Issuance of New Senior Unsecured Convertible Bonds due 2024

Santhera Pharmaceuticals Holding AG: Santhera Announces Settlement of Exchange Offer and Issuance of New Senior Unsecured Convertible Bonds due 2024 Pratteln, Switzerland, s the settlement of the e . Santhera Pharmaceuticals Holding AG is settling today its offer to exchange its outstanding CHF 60 million 5% Convertible Bonds due 2022 (the 2017/22 Bonds) on the terms set out in the Notice of Repurchase Offer dated March 25, 2021 (the Exchange Offer). Upon settlement, 2017/22 Bonds in the aggregate principal amount of CHF 15,155,000 remain in circulation. Santhera will issue today Senior Unsecured Convertible Bonds due 2024 (the 2021/24 Bonds) in the aggregate principal amount of CHF 30,270,375, on the terms set out in the issuance and listing prospectus dated May 4, 2021, to those holders of the 2017/22 Bonds who accepted the Exchange Offer. The principal amount/denomination of the 2021/24 Bonds is CHF 3,375 per bond, with a conversion price of CHF 3.00 and a conversi

Pratteln
Switzerland-general
Switzerland
United-states
United-kingdom
Swiss
Eva-kalias
Basler-kantonalbank
Santhera-pharmaceuticals
Head-external-communications
Financial-services
Bonds

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.